News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
326,475 Results
Type
Article (18216)
Company Profile (31)
Press Release (308227)
Multimedia
Podcasts (26)
Webinars (10)
Section
Business (88897)
Career Advice (953)
Deals (15152)
Drug Delivery (36)
Drug Development (46759)
Employer Resources (54)
FDA (8395)
Job Trends (6613)
News (161024)
Policy (15445)
Tag
Academia (1615)
Accelerated approval (6)
Adcomms (14)
Allergies (49)
Alliances (22516)
ALS (75)
Alzheimer's disease (1097)
Antibody-drug conjugate (ADC) (81)
Approvals (8496)
Artificial intelligence (133)
Autoimmune disease (12)
Automation (13)
Bankruptcy (145)
Best Places to Work (5687)
BIOSECURE Act (4)
Biosimilars (60)
Biotechnology (24)
Bladder cancer (90)
Brain cancer (21)
Breast cancer (205)
Cancer (1811)
Cardiovascular disease (171)
Career advice (790)
Career pathing (24)
CAR-T (99)
CDC (15)
Cell therapy (265)
Cervical cancer (13)
Clinical research (39124)
Collaboration (517)
Company closure (1)
Compensation (241)
Complete response letters (15)
COVID-19 (1252)
CRISPR (25)
C-suite (204)
Cystic fibrosis (61)
Data (2447)
Denatured (5)
Depression (40)
Diabetes (237)
Diagnostics (3010)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (18)
Drug discovery (80)
Drug pricing (41)
Drug shortages (17)
Duchenne muscular dystrophy (121)
Earnings (37476)
Editorial (10)
Employer branding (1)
Employer resources (47)
Events (44086)
Executive appointments (386)
FDA (9677)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (457)
Gene editing (60)
Generative AI (12)
Gene therapy (297)
GLP-1 (471)
Government (2348)
Grass and pollen (2)
Guidances (235)
Healthcare (9513)
HIV (22)
Huntington's disease (10)
IgA nephropathy (39)
Immunology and inflammation (64)
Immuno-oncology (3)
Indications (27)
Infectious disease (1357)
Inflammatory bowel disease (74)
Inflation Reduction Act (1)
Influenza (42)
Intellectual property (79)
Interviews (133)
IPO (7069)
IRA (14)
Job creations (1127)
Job search strategy (700)
Kidney cancer (7)
Labor market (21)
Layoffs (170)
Leadership (14)
Legal (2942)
Liver cancer (47)
Longevity (6)
Lung cancer (267)
Lymphoma (159)
Machine learning (6)
Management (21)
Manufacturing (186)
MASH (114)
Medical device (6235)
Medtech (6244)
Mergers & acquisitions (8467)
Metabolic disorders (585)
Multiple sclerosis (61)
NASH (19)
Neurodegenerative disease (85)
Neuropsychiatric disorders (14)
Neuroscience (1564)
NextGen: Class of 2025 (2822)
Non-profit (2150)
Now hiring (42)
Obesity (244)
Opinion (99)
Ovarian cancer (54)
Pain (90)
Pancreatic cancer (80)
Parkinson's disease (120)
Partnered (9)
Patents (152)
Patient recruitment (136)
Peanut (26)
People (27023)
Pharmaceutical (10)
Pharmacy benefit managers (7)
Phase I (11415)
Phase II (17434)
Phase III (13325)
Pipeline (1501)
Policy (84)
Postmarket research (1566)
Preclinical (5235)
Press Release (26)
Prostate cancer (74)
Psychedelics (13)
Radiopharmaceuticals (134)
Rare diseases (277)
Real estate (1907)
Recruiting (20)
Regulatory (11755)
Reports (16)
Research institute (1205)
Resumes & cover letters (149)
Rett syndrome (9)
RNA editing (5)
RSV (32)
Schizophrenia (72)
Series A (66)
Series B (53)
Service/supplier (5)
Sickle cell disease (31)
Special edition (1)
Spinal muscular atrophy (71)
Sponsored (10)
Startups (1506)
Stomach cancer (4)
Supply chain (35)
Tariffs (10)
The Weekly (21)
Vaccines (352)
Venture capital (17)
Weight loss (132)
Women's health (18)
Worklife (9)
Date
Last 7 days (240)
Last 30 days (982)
Last 365 days (15830)
2025 (10946)
2024 (17992)
2023 (20398)
2022 (28647)
2021 (30120)
2020 (27769)
2019 (22366)
2018 (17142)
2017 (15778)
2016 (14695)
2015 (17940)
2014 (12955)
2013 (10332)
2012 (11053)
2011 (11404)
2010 (10165)
Location
Africa (331)
Alabama (27)
Arizona (65)
Arkansas (4)
Asia (28832)
Australia (4600)
California (4154)
Canada (1396)
China (488)
Colorado (147)
Connecticut (187)
Delaware (106)
Europe (43956)
Florida (559)
Georgia (149)
Idaho (24)
Illinois (325)
India (26)
Indiana (195)
Iowa (8)
Japan (193)
Kansas (72)
Kentucky (11)
Louisiana (12)
Maine (42)
Maryland (511)
Massachusetts (2767)
Michigan (96)
Minnesota (190)
Mississippi (2)
Missouri (37)
Montana (11)
Nebraska (12)
Nevada (52)
New Hampshire (32)
New Jersey (1373)
New Mexico (8)
New York (1258)
North Carolina (592)
North Dakota (5)
Northern California (1944)
Ohio (128)
Oklahoma (2)
Oregon (18)
Pennsylvania (893)
Puerto Rico (11)
Rhode Island (5)
South America (474)
South Carolina (14)
South Dakota (1)
Southern California (1654)
Tennessee (66)
Texas (627)
United States (14998)
Utah (121)
Virginia (111)
Washington D.C. (37)
Washington State (379)
West Virginia (2)
Wisconsin (26)
326,475 Results for "hurley consulting associates ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP)
August 22, 2025
·
6 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September 2025
August 25, 2025
·
1 min read
Press Releases
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
August 28, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results
August 19, 2025
·
2 min read
Press Releases
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
August 15, 2025
·
18 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.
September 4, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August 2025
August 5, 2025
·
2 min read
Press Releases
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
September 4, 2025
·
13 min read
1 of 32,648
Next
